Posted on 2/18/21
Integra LifeSciences Reports Fourth Quarter and Full-Year 2020 Financial Results
PRINCETON, N.J., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full-year ended December . . .
Posted on 2/18/21
Johnson & Johnson's COVID-19 Vaccine Inventory Is Lighter Than Expected
The White House COVID-19 Response Team held a briefing on Wednesday where Joe Biden's recently appointed COVID-19 response coordinator, Jeff Zients, told the public some news . . .
Posted on 2/17/21
Citius Pharmaceuticals Prices $76.5 Million Registered Direct Offering
Citius Pharmaceuticals, Inc. (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, today announced that it has entered into definitive . . .
Posted on 2/17/21
Caladrius Biosciences Closes $65 Million Registered Direct Offerings
BASKING RIDGE, N.J., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed . . .
Posted on 2/17/21
Cedar Partners With Summit CityMD to Offer a New, Patient-Forward Financial Experience
Cedar's end-to-end patient engagement platform will give millions of patients across New York and New Jersey a consumer-centric digital experience at every step of the revenue . . .
Posted on 2/16/21
Onconova Therapeutics Closes $28.75M Public Offering of Common Stock
NEWTOWN, Pa., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to treat . . .
Posted on 2/16/21
Zoetis Reports Fourth Quarter and Full Year 2020 Results
PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS) today reported its financial results for the fourth quarter and full year 2020 and provided full year guidance for 2021.The . . .
Posted on 2/16/21
Outlook Therapeutics Reports Financial Results for First Quarter Fiscal Year 2021 and Provides Corporate Update
MONMOUTH JUNCTION, N.J., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved ophthalmic . . .
Posted on 2/16/21
Teleflex Named One of America’s Best Employers 2021 by Forbes
WAYNE, Pa., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), has been recognized as part of Forbes’ list of America’s Best Employers 2021. The . . .
Posted on 2/16/21
Hepion Pharmaceuticals Prices of Public Offering
EDISON, N.J., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on the development of therapeutic drugs for the . . .
Posted on 2/16/21
Here's Why You Can't Compare Vaccine Results Between Johnson & Johnson, Pfizer, and Moderna
Johnson & Johnson (NYSE:JNJ) announced late-stage results for its COVID-19 vaccine in late January. The immediate focus was on the vaccine's efficacy, which was markedly lower . . .
Posted on 2/16/21
What's the Outlook for Pfizer Stock?
Pfizer (NYSE:PFE) underperformed the S&P 500 in 2020. And in 2019. And in 2017. And in 2016. You probably noticed I skipped 2018 -- that was . . .
Posted on 2/16/21
Better Coronavirus Stock: Inovio Pharmaceuticals vs. Vaxart
For some small biotechs, the race to develop a COVID-19 vaccine represented an opportunity to secure funding and establish partnerships that could serve as lifelines long . . .
Posted on 2/15/21
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today announced the grant . . .
Posted on 2/12/21
Caladrius Biosciences Announces $65 Million Registered Direct Offerings
BASKING RIDGE, N.J., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed . . .
Posted on 2/12/21
3 Reasons Pfizer's Failures Could Lead to a Big Acquisition
When Pfizer (NYSE:PFE) included statistics in its recent earnings release showing its pipeline performance over the past five years, there was a not-so-subtle message. The blue-chip . . .
Posted on 2/12/21
Johnson & Johnson's Coronavirus Vaccine Data Isn't as Bad as It First Appears
In this video from Motley Fool Live, recorded on Feb. 1, Fool.com Contributors Brian Orelli and Keith Speights discuss the phase 3 clinical trial results for . . .
Posted on 2/11/21
VYNE Therapeutics Announces Reverse Stock Split
BRIDGEWATER, N.J., Feb. 11, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) today announced that its Board of Directors has approved a reverse stock split . . .
Posted on 2/11/21
What Are Pfizer's Prospects in 2021 and Beyond?
Pfizer(NYSE:PFE) missed Wall Street's earnings estimate when the big drugmaker reported its fourth-quarter results recently. However, those results didn't account for the tremendous growth that the . . .
Posted on 2/11/21
Ortho Clinical Diagnostics: What You Need to Know
In this episode of Industry Focus: Wildcard, host Jason Moser and Motley Fool contributor Brian Feroldi take a closer look at Ortho Clinical Diagnostics' (NASDAQ:OCDX) debut . . .
Posted on 2/11/21
Onconova Therapeutics Prices of $25 Million Public Offering of Common Stock
NEWTOWN, Pa., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a biopharmaceutical company focused on discovering and developing novel products to treat cancer, . . .
Posted on 2/11/21
Ocugen Closes $23M Registered Direct Offering of Common Stock
MALVERN, Pa., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Nasdaq: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness . . .
Posted on 2/10/21
Onconova Therapeutics Proposes Public Offering of Common Stock
NEWTOWN, Pa., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a biopharmaceutical company focused on discovering and developing novel products to treat cancer, . . .
Posted on 2/10/21
Healthcare Services Group Reports Q4 2020 Results
BENSALEM, PA--(BUSINESS WIRE)--Healthcare Services Group, Inc. (NASDAQ:HCSG) reported for the three months ended December 31, 2020 revenue of $423.2 million, net income of $27.7 million, or . . .
Posted on 2/10/21
Catalent Launch of Private Offering of $475 Million of Senior Unsecured Notes
SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and . . .
Philadelphia
